SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova acquires 19.89% stake in O2 Renewable Energy XVI

07 Jun 2024 Evaluate

Jubilant Pharmova has completed acquisition of 19.89% stake in O2 Renewable Energy XVI (O2) i.e. 75,903 Compulsory Convertible Debentures (CCDs) of face value of Rs 1,000 each and 8,43,362 Equity shares of face value of Rs 10 each. On March 29, 2024, the company had acquired 64,517 CCDs and 7,16,857 equity shares in O2. 

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

996.85 -11.75 (-1.16%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×